Location History:
- Pasadena, CA (US) (1996 - 2000)
- Altadena, CA (US) (2004 - 2006)
- Lincolnshire, IL (US) (2013 - 2015)
Company Filing History:
5 out of 2,483 
2 out of 10 
2 out of 1,152 
Years Active: 1996-2015
Title: Sam L Helgerson: Innovator in Fibrin Sealants
Introduction
Sam L Helgerson is a notable inventor based in Lincolnshire, IL (US). He has made significant contributions to the field of medical technology, particularly in the development of fibrin sealants. With a total of 8 patents, his work has had a profound impact on therapeutic applications.
Latest Patents
One of Helgerson's latest patents is titled "Fibrin gel for controlled release of PDGF and uses thereof." This invention relates to fibrin sealants that contain platelet-derived growth factor (PDGF) for controlled release in situ. The therapeutic applications of this invention include treatment for musculoskeletal disorders, soft tissue disorders, and vascular diseases. His innovative approach aims to enhance the effectiveness of fibrin sealants in various medical applications.
Career Highlights
Throughout his career, Helgerson has worked with prominent companies in the medical field. Notably, he has been associated with Baxter International Inc. and Nexell Therapeutics Inc. His experience in these organizations has allowed him to develop and refine his inventions, contributing to advancements in medical technology.
Collaborations
Helgerson has collaborated with several professionals in his field, including Joseph Edward Curtis and Janet Tseng-Law. These collaborations have fostered innovation and have been instrumental in the development of his patented technologies.
Conclusion
Sam L Helgerson is a distinguished inventor whose work in fibrin sealants has paved the way for advancements in therapeutic applications. His contributions continue to influence the medical field, showcasing the importance of innovation in healthcare.